Reinier Haga Medisch Diagnostisch Centrum

What Reinier Haga Medisch Diagnostisch Centrum does

Reinier Haga Medisch Diagnostisch Centrum (RHMDC) is a nationwide Dutch medical diagnostic center and a subsidiary of the Reinier de Graaf Groep, headquartered in Delft. The organization consolidates five laboratory disciplines under one roof — clinical chemistry, medical immunology, medical microbiology, pathology, and a dedicated anticoagulation unit (Trombosedienst) — alongside Point of Care Testing (POCT) deployment services. It serves general practitioners, midwives, hospitals (including Reinier de Graaf Gasthuis and HagaZiekenhuis Zoetermeer), GGZ institutions, nursing homes, occupational health providers (KLM Health Services, Port Health Centre), and thrombosis patients across the Netherlands. Operations span a 24/7 central laboratory in Delft, pre-processing labs in Hoofddorp, Heerlen, and Spijkenisse, plus over 100 blood collection locations distributed nationwide.

The core technology stack combines Abbott-automated clinical chemistry equipment (reducing energy use by up to 30%) with a network of digital integrations: ZorgDomein for referral ordering, Chipsoft electronic patient records shared with the hospital group, HC@Home for POCT result transmission into practice HIS, and the Tropaz platform for thrombosis patient self-monitoring. POCT devices (CRP meters, glucose meters, urine meters) and CoaguChek XS self-monitoring devices are loaned free of charge to practices and patients, with consumables ordered through an online webshop. The organization holds ISO 15189, ISO 22870, NEN 7510, and IVDR compliance accreditations, and was the first in the Netherlands to offer CE-IVD pharmacogenetic testing in collaboration with Erasmus MC. Recent technology development includes validation of the SoundCell MelodyOne acoustic device for rapid antibiotic susceptibility testing within the microbiology department.

RHMDC operates a B2B sales-led model targeting healthcare providers, supported by regional relationship managers and digital ordering platforms, with a B2C channel for patient-initiated bookings and self-monitoring. Revenue is generated primarily through NZA-regulated tariff reimbursement for laboratory diagnostics covered under Dutch basic health insurance (subject to policyholder deductible), supplemented by consumables revenue from POCT device usage, enterprise contracts with occupational health clients, and premium services such as pharmacogenetics. The organization is led by General Director Ruben Baumgarten and Deputy Director Ivo Kristelijn, with approximately 501-1000 employees across all disciplines.

Name

Reinier Haga Medisch Diagnostisch Centrum

Legal name

Reinier Haga Medisch Diagnostisch Centrum

Website

https://rhmdc.nl

Company type

Private

Operating status

Operating

Headcount range

501–1,000 employees

Short description

RHMDC is a Dutch nationwide medical diagnostic center operating 100+ blood collection sites, providing laboratory diagnostics in clinical chemistry, immunology, microbiology, pathology, and anticoagulation management to GPs, hospitals, midwives, and thrombosis patients across the Netherlands.

Ownership category

akta.pro rank

Product category

Medical Laboratory Diagnostics

NAICS

Medical Laboratories (621511), Medical and Diagnostic Laboratories (62151), Medical and Diagnostic Laboratories (6215)

SIC

Services-Medical Laboratories (8071)

akta.pro primary industry

Point-of-Care & Decentralized Trial Testing Services (HLAGAEAK)

akta.pro secondary industry

Central Laboratory & Clinical Trial Testing CROs (HLAGAAAE)

Keywords

• Medical laboratory diagnostics
• Clinical chemistry services
• Anticoagulation management
• Point of care testing
• Pathology services

Headquarters

HQ city

Delft

HQ country

Netherlands

HQ region

Europe

Offices7 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Infrastructure, Supply Chain

Revenue model

1. Laboratory Diagnostic Services: RHMDC provides a wide range of laboratory diagnostic tests (blood, urine, tissue, feces, etc.) to healthcare providers. Services are reimbursed through Dutch health insurance at NZA-regulated tariff rates, with costs applied against the patient's deductible (own risk).
2. Anticoagulation Management (Trombosedienst): Ongoing monitoring and dosing of anticoagulation medication (VKA: acenocoumarol, fenprocoumon, warfarin) for thrombosis patients. Covered under basic health insurance, subject to deductible. Includes training and periodic controls for self-measuring patients.
3. POCT Equipment and Consumables: Point of Care Testing devices (CRP meters, glucose meters, urine meters) provided free of charge to healthcare practices, with reagents and consumables ordered via the webshop. Reimbursement follows standard diagnostic tariff structures.

Pricing tiers

Go-to-market motion2 records

Distribution channels5 records

Marketing channels6 records

Core offering

RHMDC is a Dutch medical diagnostic center that provides clinical chemistry, medical microbiology, medical immunology, pathology, and pharmacogenetic testing through routine analyses of blood, urine, feces, semen, and tissue samples, plus fundus photography and STI testing. It also runs the regional Trombosedienst (anticoagulation service), deploys and maintains Point of Care Testing (POCT) equipment such as glucose and CRP meters at GP practices, and operates self-monitoring programs with online portals for patients on long-term anticoagulation.

Product overview

RHMDC is a nationwide medical diagnostic center offering a comprehensive laboratory diagnostics platform with all disciplines under one roof: Clinical Chemistry, Medical Immunology, Medical Microbiology, and Pathology, plus a dedicated Anticoagulation Service (Trombosedienst). The core offering centers on blood, urine, feces, and tissue testing conducted at over 100 collection sites across the Netherlands, with results typically available same-day. Supplementary modules include Point of Care Testing (POCT) equipment provided to practices for rapid in-office diagnostics, a self-monitoring INR program with Tropaz digital platform, pharmacogenetic testing in partnership with Erasmus MC, and equipment loan programs. The organization serves general practitioners, hospitals, midwives, occupational health services, and specialized clinics, operating 24/7 with a central laboratory in Delft.

Differentiator

Problem solved

Functional benefit

Products and services

• Blood Testing (Bloedonderzoek) Routine and specialized blood analysis covering clinical chemistry, haematology, immunology, and pharmacogenetic panels, ordered by GPs, midwives, and hospitals via ZorgDomein and reported electronically the same day.
• Urine Testing (Urineonderzoek) Routine urine chemistry and microscopy testing for primary and antenatal care, with same-day electronic results.
• Feces Testing (Fecesonderzoek) Stool sample diagnostics, including parasitology and microbiology testing, ordered by GPs and reported via ZorgDomein.
• Semen Analysis (Spermaonderzoek) Semen analysis as part of reproductive health diagnostics, ordered by GPs, midwives, and fertility specialists.
• Fundus Photography (Fundusfotografie) Retinal imaging for screening and diagnostic assessment, typically used in diabetes care and ophthalmology pathways.
• STI/STD Testing (SOA Onderzoek)
• Anticoagulation Service / Trombosedienst Regional anticoagulation clinic service providing INR monitoring, dosing, and clinical-chemical support for patients on vitamin K antagonists and other anticoagulant therapy, delivered via blood collection sites, the MYKOBI care provider portal, and the Tropaz self-monitoring portal.
• Pharmacogenetics (Farmacogenetica)
• Point of Care Testing (POCT) Equipment Deployment Deployment of CRP, glucose, and urine analyzers (including CareSens N Premier) at primary care practices, including device supply, maintenance, training, and ISO 22870 quality assurance.
• INR Self-Monitoring Program Subscription-based home INR self-monitoring program, providing CoaguChek XS devices, training, dosing guidance via the Tropaz portal, and clinical-chemical helpdesk support.
• Medical Equipment Loan Program

Quantifiable outcome

• Same-day results for most laboratory determinations
• +3 more outcomes

Named customers7 records

Segments6 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration6 records

Feature5 records

Partnerships

14 partnerships are on record, tiered flagship, minor and core.

• EVAA (Eerstelijns Verloskundigen Amsterdam-Amstelland)flagshipStrategic or Co-development Partner · 1 January 2025EVAA is a network of primary care midwives in Amsterdam-Amstelland. The collaboration enables midwives to facilitate blood collection for pregnancy diagnostics including NIPT directly in their practices. RHMDC provides the associated diagnostics. This makes care more accessible and prevents unnecessary hospital visits.
• SoundCellminorStrategic or Co-development Partner · 1 January 2025RHMDC collaborates with SoundCell on the MelodyOne: a device that 'listens' to movements of active bacteria to determine the optimal antibiotic within one hour. The promising technology is currently being validated in RHMDC's microbiology department.
• AbbottcoreTechnology or Integration · 1 January 2024RHMDC selected Abbott diagnostic equipment to modernize and automate its clinical chemistry laboratory processes. Abbott's technology enables scale, higher efficiency, and sustainability — reducing plastic waste, water consumption, and up to 30% energy use. Routine manual tasks like tube sorting and retrieval are now automated.
• Trombovitaal (Vital10)coreStrategic or Co-development PartnerTrombovitaal provides complete care for patients on anticoagulation medication. RHMDC determines INR values, after which Trombovitaal creates a new dosing schedule for the patient. This partnership enhances patient service and helps prevent clot extension and recurrence.
• Erasmus MCcoreTechnology or IntegrationRHMDC and the Clinical Chemistry department of Erasmus MC jointly perform CE-IVD quality tests for more than 20 enzymes as the first in the Netherlands, enabling pharmacogenetic analysis. For drug level measurements, RHMDC collaborates with the hospital pharmacy at Reinier de Graaf Gasthuis.
• PluhzcoreStrategic or Co-development PartnerPluhz expands specialist care into primary care settings. RHMDC is the first medical diagnostic center in the Netherlands to offer a complete specialist package in primary care through this partnership, enabling blood collection and function testing (ECG, imaging) at general practices via the ZoekBoekZorg platform.
• KLM Health ServicescoreStrategic or Co-development PartnerKLM Health Services partnered with RHMDC for a complete laboratory services package covering all KLM locations in the Randstad and Schiphol. Services include blood tests, body material analysis, and virus/parasite testing. RHMDC acts as a collaborative partner rather than a static supplier.
• Port Health CentreminorStrategic or Co-development PartnerPort Health Centre serves the maritime and industrial sector with medical services. RHMDC provides rapid diagnostic testing including QuantiFeron TB tests with logistics and analysis turnaround within 24 hours, demonstrating flexible service delivery for the maritime industry.
• One Day ClinicminorStrategic or Co-development PartnerOne Day Clinic is a private clinic specializing in STD prevention, diagnosis, and treatment. RHMDC provides laboratory testing services and enables rapid, anonymous digital result delivery for One Day Clinic and its clients.
• Julius Instituut (UMC Utrecht)minorStrategic or Co-development PartnerRHMDC collaborates with the Julius Centre for Health Sciences and Primary Care at UMC Utrecht on the PECAN study, investigating whether pulmonary embolism diagnosis can be safely and reliably performed in general practice. The study runs approximately two years in collaboration with LUMC.
• Federatie van Nederlandse Trombosediensten (FNT)coreStrategic or Co-development PartnerRHMDC's Unit Antistolling is an active member of the FNT. RHMDC staff actively participate in regional meetings between thrombosis services and hospitals in the Delft, Den Haag, Leiden, and Zoetermeer regions.
• Reinier de Graaf GasthuiscoreStrategic or Co-development PartnerRHMDC is part of the Reinier de Graaf group and shares certain systems including Chipsoft electronic patient records. The Gasthuis handles billing and declarations for RHMDC services. RHMDC also provides blood collection for the hospital and collaborates on anticoagulation policy.
• HagaZiekenhuis ZoetermeercoreStrategic or Co-development PartnerRHMDC provides blood collection services for HagaZiekenhuis Zoetermeer and is closely involved in anticoagulation policy. Both organizations participate in regional meetings with thrombosis services in the Delft, Den Haag, Leiden, and Zoetermeer region.
• Delfts Allergie Centrum (Reinier de Graaf Gasthuis)minorStrategic or Co-development PartnerRHMDC's Medical Immunology department collaborates closely with the Delft Allergy Centre at Reinier de Graaf Gasthuis, leveraging shared expertise in allergy diagnostics.

Scale indicators4 records

Recent moves6 records

Expansion highlights6 records

Broad incumbents

• Synlab: Synlab is Europe's largest clinical laboratory chain operating across multiple countries with comprehensive routine and specialty diagnostics, including Dutch operations. It is a broader incumbent with far greater scale and pan-European reach, but overlaps with RHMDC in routine clinical chemistry and POCT services in the Netherlands.
• Eurofins Scientific: Eurofins is a global leader in bioanalytical testing with clinical diagnostics operations in the Netherlands. As a broad incumbent, it offers overlapping routine and specialty laboratory services but operates at vastly greater scale and scope than RHMDC's domestic Dutch focus.
• Unilabs: Unilabs is a pan-European clinical diagnostics and specialty laboratory operator with Dutch operations. Comparable to RHMDC in clinical chemistry and specialty testing for hospitals and GPs, but with significantly larger scale and broader geographic footprint.

Direct peers

• Certe: Certe is a Dutch clinical laboratory headquartered in Groningen serving the northern Netherlands with clinical chemistry, microbiology, pathology, and immunology services for GPs, hospitals, and public health authorities. Comparable to RHMDC in its regional multi-discipline lab offering and Trombosedienst-style anticoagulation services.
• Medlon: Medlon is a Dutch clinical laboratory associated with hospital groups in the eastern Netherlands, providing clinical chemistry, microbiology, and specialized diagnostics to regional healthcare providers. Comparable to RHMDC as a multi-discipline Dutch lab embedded within a hospital-system context.
• Result Laboratorium: Result Laboratorium is a Dutch clinical laboratory offering routine and specialized diagnostics to healthcare providers. It is a regional Dutch peer to RHMDC with overlapping service portfolio in clinical chemistry, immunology, and infectious disease testing for primary care.
• Star-SHL (Stichting Samenwerkende Ziekenhuizen Rotterdam): Star-SHL is a Rotterdam-based medical diagnostic center providing routine laboratory testing, anticoagulation management, and specialized diagnostics to GPs, midwives, and hospitals in the Rijnmond region. It mirrors RHMDC's multi-disciplinary lab-plus-Trombosedienst model and competes for similar Dutch primary-care referrals.
• Saltro: Saltro is a major Dutch medical diagnostic center operating primarily in the Utrecht region, offering clinical chemistry, microbiology, and specialized testing to GPs, hospitals, and occupational health. It is the most directly comparable full-service Dutch diagnostic lab to RHMDC in scope, scale, and customer mix.
• LabNed: LabNed is a Dutch network of regional clinical laboratories providing diagnostic services to primary care and hospitals across multiple provinces. Comparable to RHMDC as a multi-site Dutch medical diagnostic operator with NZA-tariff reimbursement and similar customer base of GPs and specialists.

Others

• Abbott Diagnostics: Abbott is RHMDC's primary diagnostic equipment supplier and modernization partner for clinical chemistry automation. While not a direct competitor, Abbott's platform investments materially shape RHMDC's economics and competitive positioning versus other Dutch labs.

Market position

Strengths1 record

Weaknesses1 record

Competitive moat6 records

Key risks6 records

Key highlights7 records

Customer concentration

Compliance6 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles7 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Reinier Haga Medisch Diagnostisch Centrum